FRUQUINTINIB
fruquintinib 1 mg capsule, 21
FRUQUINTINIB (15336E)
15336E
Manner of administration:Oral
Restriction 18516
Indication: Metastatic colorectal cancer
Treatment phase: Initial PBS-subsidised treatment
Restriction 18520
Indication: Metastatic colorectal cancer
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 4 | Max qty units: 84 | # of repeats: 5 | DPMQ: $5,438.96 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Fruzaqla | |||||